VIVO
Price:
$33.97
Market Cap:
$1.49B
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
1986-07-29
Stock Exchange
NASDAQ
Ticker
VIVO
According to Meridian Bioscience, Inc.’s latest financial reports and current stock price. The company's current ROE is -6.81%. This represents a change of 1.67% compared to the average of -0.38% of the last 4 quarters.
The mean historical ROE of Meridian Bioscience, Inc. over the last ten years is 17.79%. The current -6.81% ROE has changed -138.26% with respect to the historical average. Over the past ten years (40 quarters), VIVO's ROE was at its highest in in the June 2020 quarter at 11.79%. The ROE was at its lowest in in the December 2022 quarter at -8.76%.
Average
17.79%
Median
19.01%
Minimum
11.54%
Maximum
24.53%
Discovering the peaks and valleys of Meridian Bioscience, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 46.08%
Maximum Annual ROE = 24.53%
Minimum Annual Increase = -46.96%
Minimum Annual ROE = 11.54%
Year | ROE | Change |
---|---|---|
2022 | 11.54% | -46.96% |
2021 | 21.75% | 16.62% |
2020 | 18.65% | 46.08% |
2019 | 12.77% | -6.09% |
2018 | 13.60% | 6.95% |
2017 | 12.71% | -34.34% |
2016 | 19.36% | -9.64% |
2015 | 21.43% | -0.69% |
2014 | 21.58% | -12.04% |
2013 | 24.53% | 4.93% |
The current ROE of Meridian Bioscience, Inc. (VIVO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
17.31%
5-year avg
15.66%
10-year avg
17.79%
Meridian Bioscience, Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Meridian Bioscience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Meridian Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Meridian Bioscience, Inc.'s ROE?
How is the ROE calculated for Meridian Bioscience, Inc. (VIVO)?
What is the highest ROE for Meridian Bioscience, Inc. (VIVO)?
What is the 3-year average ROE for Meridian Bioscience, Inc. (VIVO)?
What is the 5-year average ROE for Meridian Bioscience, Inc. (VIVO)?
How does the current ROE for Meridian Bioscience, Inc. (VIVO) compare to its historical average?